Immunization

Chronic HBV increases the risk of developing liver failure, liver cancer, and cirrhosis.

The investigators said that this analysis is the most comprehensive assessment of vaccination rates among US hospital personnel to date, using data from 3.3 million HCP.

Hepatitis A is most likely to be contracted from contaminated food, water, or close contact with a person or object that's infected.

The model could help researchers and public health officials interpret the significance of existing variants and design tailored public health responses for various scenarios based on a variant’s characteristic.

Investigators have developed an encapsulated and immobilized individual bacterium cell in crystalline polymeric matric that not only kills the bacterium but preserves and stabilizes the dead cell against high temperature, moisture, and organic solvents. The method utilizes metal-organic frameworks (MOFs).

The analysis found that vaccination rates increased from 36% to 60% between January 2021 and April 2021 but then slowed, reaching just 70% as of September 2021.

A survey of caregivers and parents of children with cancer shows that nearly one-third expressed hesitancy to vaccinate their youngsters against COVID-19.

Their statement also calls upon the business community to support the new federal requirement that individuals working for companies with more than 100 employees be vaccinated.

After 6 to 7 months, just 8 individuals contracted proven symptomatic SARS-CoV-2 infection with rapid favorable evolution, study results show.

Several states lead charge to update immunization protocols, allowing vaccine administration.

Melissa Pein, a pharmacy technician supervisor at Children’s Mercy Kansas City Hospital, discusses the role pharmacy technicians play in vaccinations.

Study results show that the type of vaccine patients received was a major factor in inducing an immune response, with those receiving mRNA shots faring better.

Study results show that those with lymphoproliferative disorders are the most likely to develop the virus after vaccination.

The company plans to submit data to the European Medicines Agency, FDA, and other global regulators.

Michael Hogue joins Ed Cohen and John Beckner to dig deeper into vaccine hesitancy, boosters, and other topics in the immunization space.

The difference between individuals who were vaccinated and had the infection were higher at different intervals than for those who were unvaccinated.

A new poll shows that this year 64% of individuals between aged 50 and 64 years say they already got or are likely to get their influenza shots up from 54% last year.

Pharmacists and technicians have an opportunity to prove their value as immunizers now that the Pfizer-BioNTech COVID-19 vaccine has been authorized for use in children ages 5 to 11.

Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.

The results of a study show that individuals who received 3 doses of the BNT162b2 vaccine had a 93% lower risk of hospitalization than those who had just 2.

Among those who were infected with the delta variant (126), 25% were fully immunized and 38% were unvaccinated, study results show.

Overall vaccine efficacy was 54.6%, which met the pre-specified endpoint for success and showed benefit across 3 influenza seasons and all 8 countries.

Linda Mendonça, DNP, RN, PHNA-BC, president of the National Association of School Nurses, discusses a new poll released by the COVID-19 Vaccine Education and Equity Project and the National Association of School Nurses about parents’ plans to vaccinate their school-aged children.

Mild dengue fever causes a high fever and flu-like symptoms.

The Keep Up the Rates campaign is aiming to encourage patients to catch up on routine vaccinations that might have been missed or delayed due to the COVID-19 pandemic.

Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.

The success of the COVID-19 messenger RNA (mRNA) vaccines from Pfizer/BioNTech and Moderna has given many HIV advocates hope that a preventive mRNA vaccine is on the horizon.